Effect of Alpinia galanga extract on cartilage degradation and on gene expression in human chondrocyte and synovial fibroblast metabolism

Central European Journal of Biology

Volumn 1, Issue 3, 2006, Pages 430-450

  Pothacharoen, Peraphan ^a   Choocheep, Kanyamas ^a   Pitak, Tanyaluck ^a   Pompimon, Wilart ^b   Premanode, Bhusana ^c   Hardingham, Timothy E ^d   Kongtawelert, Prachya ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b LAMPANG RAJABHAT UNIVERSITY   (Thailand)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alpinia galanga; Cartilage degradation; Chondrocyte; Gene expression; Synovial fibroblast

Indexed keywords

ALPINIA GALANGA;

EID: 33748299365     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-006-0030-6     Document Type: Article

References (41)

1. P.M. van der Kraan and W.B. van den Berg: "Anabolic and destructive mediators in osteoarthritis", Curr. Opin. Clin. Nutr. Metab. Care., Vol. 3, (2000), pp. 205-211.
2. F.J. Blanco, Y. Geng and M. Lotz: "Differentiation-dependent effects of IL-1 and TGF-beta on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression", J. Immunol., Vol. 154, (1995), pp. 4018-4026.
3. A.R. Shikhman, K. Kuhn, N. Alaaeddine and M. Lotz: "N- acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes", J. Immunol., Vol. 166, (2001), pp. 5155-5160.
4. A.M. Badger, M.N. Cook, B.A. Swift, T.M. Newman-Tarr, M. Gowen and M. Lark: "Inhibition of interleukin-1-induced proteoglycan degradation and nitric oxide production in bovine articular cartilage/chondrocyte cultures by the natural product, hymenialdisine", J. Pharmacol. Exp. Ther., Vol. 290, (1999), pp. 587-593.
5. M.P. Vincenti, I.M. Clark and C.E. Brinckerhoff: "Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?", Arthritis Rheum., Vol. 37, (1994), pp. 1115-1126.
6. P.G. Mitchell, H.A. Magna, L.M. Reeves, L.L. Lopresti-Morrow, S.A. Yocum, P.J. Rosner, K.F. Geoghegan and J.E. Hambor: "Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage", J. Clin. Invest., Vol. 97, (1996), pp. 761-768.
7. P. Reboul, J.P. Pelletier, G. Tardif, J.M. Cloutier and J. Martel-Pelletier: "The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis", J. Clin. Invest., Vol. 97, (1996), pp. 2011-2019.
8. Y. Okada, M. Shinmei, O. Tanaka, K. Naka, A. Kimura, I. Nakanishi, M.T. Bayliss, K. Iwata and H. Nagase: "Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium", Lab. Invest., Vol. 66, (1992), pp. 680-690.
9. G. Murphy, M.I. Cockett, P.E. Stephens, B.J. Smith and A.J. Docherty: "Stromelysin is an activator of procollagenase", A study with natural and recombinant enzymes", Biochem. J., Vol. 248, (1987), pp. 265-268.
10. R.M. Hembry, M.R. Bagga, J.J. Reynolds and D.L. Hamblen: "Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis", Ann. Rheum. Dis., Vol. 54, (1995), pp. 25-32.
11. F. Ollivierre, U. Gubler, C.A. Towle, C. Laurencin and B.V. Treadwell: "Expression of IL-1 genes in human and bovine chondrocytes: a mechanism for autocrine control of cartilage matrix degradation", Biochem. Biophy.s Res. Commun., Vol. 141, (1986), pp. 904-911.
12. W.P. Arend and J.M. Dayer: "Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis", Arthritis. Rheum., Vol. 33, (1990), pp. 305-315.
13. M. Shinmei, K. Masuda, T. Kikuchi and Y. Shimomura: "The role of cytokines in chondrocyte mediated cartilage degradation", J. Rheumatol. Suppl., Vol. 18, (1989), pp. 32-34.
14. J.P. Pelletier, R. McCollum, J.M. Cloutier and J. Martel-Pelletier: "Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1 mediated process", J. Rheumatol. Suppl., Vol. 43, (1995), pp. 109-114.
15. H. Muir: "The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules", Bioessays., Vol. 17, (1995), pp. 1039-1048.
16. J.P. Urban: "The chondrocyte: a cell under pressure", Br. J. Rheumatol. Vol. 33, (1994), pp. 901-908.
17. D. Eyre: "Collagen of articular cartilage", Arthritis. Res., Vol. 4, (2002), pp. 30-35.
18. G. Rizkalla, A. Reiner, E. Bogoch and A.R. Poole: "Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease", J. Clin. Invest., Vol. 90, (1992), pp. 2268-2277.
19. J.R. Matyas, M.E. Adams, D. Huang and L.J. Sandell: "Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis", Arthritis. Rheum., Vol. 38, (1995), pp. 420-425.
20. C.B. de Crombrugghe, V. Lefebvre and K. Nakashima: "Regulatory mechanisms in the pathways of cartilage and bone formation", Curr. Opin. Cell. Biol., Vol. 13, (2001), pp. 721-727.
21. Y. Li, S.R. Tew, A.M. Russell, K.R. Gonzalez, T.E. Hardingham and R.E. Hawkins: "Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9", Tissue. Eng. Vol. 10, (2004), pp. 575-584.
22. H. Matsuda, Y. Pongpiriyadacha, T. Morikawa, M. Ochi and M. Yoshikawa: "Gastroprotective effects of phenylpropanoids from the rhizomes of Alpinia galanga in rats: structural requirements and mode of action", Eur. J. Pharmacol. Vol. 471, (2003), pp. 59-67.
23. H. Matsuda, T. Morikawa, H. Managi and M. Yoshikawa: "Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells", Bioorg. Med. Chem. Lett., Vol. 13, (2003), pp. 3197-3202.
24. R. Grzanna, L. Lindmark and C.G. Frondoza: "Ginger-an herbal medicinal product with broad anti-inflammatory actions", J. Med. Food., Vol. 8, (2005), pp. 125-132.
25. T. Morikawa, S. Ando, H. Matsuda, S. Kataoka, O. Muraoka and M. Yoshikawa: "Inhibitors of nitric oxide production from the rhizomes of Alpinia galanga: structures of new 8-9′ linked neolignans and sesquineolignan", Chem. Pharm. Bull. (Tokyo). Vol. 53, (2005), pp. 625-630.
26. T. Decker and M.L. Lohmann-Matthes: "A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity", J. Immunol. Methods. Vol. 115, (1988), pp. 61-69.
27. R.W. Farndale, D.J. Buttle and A.J. Barrett: "Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue", Biochim. Biophys. Acta., Vol. 883, (1986), pp. 173-177.
28. N. Blumenkrantz and G. sboe-Hansen: "New method for quantitative determination of uronic acids", Anal. Biochem., Vol. 54, (1973), pp. 484-489.
29. P. Kongtawelert and P. Ghosh: "A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique", Anal. Biochem., Vol. 185, (1990), pp. 313-318.
30. L. Marchuk, P. Sciore, C. Reno, C.B. Frank and D.A. Hart: "Postmortem stability of total RNA isolated from rabbit ligament, tendon and cartilage", Biochim. Biophys. Acta, Vol. 1379, (1998), pp. 171-177.
31. R. Boykiw, P. Sciore, C. Reno, L. Marchuk, C.B. Frank and D.A. Hart: "Altered levels of extracellular matrix molecule mRNA in healing rabbit ligaments", Matrix Biol., Vol. 17, (1998), pp. 371-378.
32. A. Ito, T. Nose, S. Takahashi and Y. Mori: "Cyclooxygenase inhibitors augment the production of pro-matrix metalloproteinase 9 (progelatinase B) in rabbit articular chondrocytes", FEBS Lett., Vol. 360, (1995), pp. 75-79.
33. D.D. Taub and J.J. Oppenheim: "Chemokines, inflammation and the immune system", Ther. Immunol., Vol. 1, (1994), pp. 229-246.
34. J.A. Mengshol, M.P. Vincenti, C.I. Coon, A. Barchowsky and C.E. Brinckerhoff: "Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3", Arthritis. Rheum., Vol. 43, (2000), pp. 801-811.
35. M. Lingetti, P.L. D'ambrosio, F. Grezia, P. Sorentino and E. Lingetti: "A controlled study in the treatment of osteoarthritis with diacerein (Artrodar)", Curr. Therp. Res., Vol. 31, (1982), pp. 408-412.
36. R. Marcolonge, A. Fioravanti, S. Adami, E. Tozzi, M. Mian and A. Zampieri: "Efficacy and tolerability of diacerein in the treament of osteoarthrosis", Curr. Therp. Res., Vol. 37, (1988), pp. 529-536.
37. M. Nguyen, M. Dougados, L. Berdah and B. Amor: "Diacerhein in the treatment of osteoarthritis of the hip", Arthritis. Rheum., Vol. 37, (1994), pp. 529-536.
38. B. Mazieres and L. Berda: "Effect of diacerein (ART 50) on an experimental post-contusive model of OA", Osteoarthritis Cart., Vol. 1, (1993), p. 47.
39. K.D. Brandt, G. Smith, S.Y. Kang, S. Mayer, B. O'Corner and M. Albrecht: "Effects of diacerhein in an accelerated canine model of osteoarthritis", Osteoarthritis Cart., Vol. 5, (1997), pp. 438-439.
40. G.N. Smith, Jr., S.L. Myers, K.D. Brandt, E.A. Mickler and M.E. Albrecht: "Diacerhein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis", Arthritis Rheum., Vol. 42, (1999), pp. 545-554.
41. T. Tamura, N. Kosaka, J. Ishiwa, T. Sato, H. Nagase and A. Ito: "Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes", Osteoarthritis. Cartilage., Vol. 9, (2001), pp. 257-263.